Generic Drugmakers Struggle Despite Us Push For Copycats | Latest News RSS feed

Generic Drugmakers Struggle Despite Us Push For Copycats - Latest News


Generic Drugmakers Get Boost as FDA Move Helps Complex Copycats

Read more: Generic drugmakers struggle despite U.S. push for copycats There are only a few birth-control patches on the market, including CombiPatch, and more than 182,000 prescriptions were written l... read more

Generic drugs' troubled source

As U.S. regulators push hundreds of new generic drugs to market in an effort to drive down prices, the industry is facing a continuing problem in India, where many copycat medicines ... sending produc... read more

Amgen Wins Reprieve on Its 2nd-Best-Selling Drug

That may mean it's only a matter of time before generic drug companies, including Mylan (NASDAQ: MYL), win FDA approval of biosimilar copycats ... to the tune of about $12 million per day. Despite Myl... read more

Looking for another news?


Analysis: Roche stays a step ahead of copycat drugmakers

Generic copies, therefore, are more difficult to develop and market. While rival drugmakers ... Roche to push back to early 2016 the date it expects the first MabThera biosimilar, meaning that sales o... read more


Drug companies rake in billions off ‘snort-proof’ opioids

But it’s also a multibillion-dollar sales opportunity, offering drugmakers the potential to wipe out lower-cost generic competitors and lock ... will give drugmakers momentum to successfully push for ... read more

FTC sees return of pacts to thwart generic competition

The US Federal Trade Commission says the top pharmaceutical companies have resumed the practice of paying generic drug manufacturers to keep copycat versions of brandname medicines off the market, des... read more

Talking Point: Nintendo Should Aim to Produce Mature, Genre-Defining Storytelling Experiences

The Last of Us is a title that, despite the occasional moment that's frustrated ... but some also want games centered on a more real world, tales of struggle based around human endeavour, that also pu... read more

Amgen Wins Reprieve on Its 2nd-Best-Selling Drug

That may mean it's only a matter of time before generic drug companies, including Mylan (NASDAQ: MYL), win FDA approval of biosimilar copycats. Unfortunately ... to $196 million. Amgen's struggle to m... read more

Switzerland takes on its top drugmakers in price row

ZURICH, Sept 16 (Reuters) - Switzerland, home to the world’s two biggest drugmakers ... copycat drugs. Both Roche and Novartis remain sanguine that healthcare authorities and insurance companies will ... read more

Switzerland takes on its top drugmakers in price row

Their demands that medicine prices be cut is a growing challenge for drugmakers ... copycat drugs. Both Roche and Novartis remain sanguine that healthcare authorities and insurance companies will stil... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us